Detalles de la búsqueda
1.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Lancet Oncol
; 25(4): 463-473, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467131
2.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314897
3.
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.
Int J Mol Sci
; 24(17)2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685994
4.
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Blood
; 135(24): 2137-2145, 2020 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219442
5.
Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers.
Medicina (Kaunas)
; 58(10)2022 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295492
6.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Br J Haematol
; 192(6): 978-987, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862447
7.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30602617
8.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583077
9.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523289
10.
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
Medicina (Kaunas)
; 57(8)2021 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34441032
11.
B-cell oligoclonal expansions in renal tissue of patients with immune-mediated glomerular disease.
Clin Immunol
; 217: 108488, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479988
12.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495951
13.
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.
Blood
; 140(25): 2754-2756, 2022 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112968
14.
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.
Ann Hematol
; 98(6): 1383-1392, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30877373
15.
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Lancet Oncol
; 19(6): 747-757, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735299
16.
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Hematol Oncol
; 36(4): 693-700, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30129144
17.
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Hematol Oncol
; 36(1): 174-181, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28219112
18.
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
Hematol Oncol
; 36(4): 645-650, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882363
19.
Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.
Eur J Haematol
; 100(2): 131-139, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29105864
20.
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Am J Hematol
; 93(7): 895-901, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659040